维普期刊资源整合服务平台（V6.5）

232篇 您的检索式：期刊名="Value In Health"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	The Cost-Effectiveness of an Extended Course (12 + 12 Weeks) of Varenicline Compared with Other Available Smoking Cessation Strategies in the United States: An Extension and Update to the BENESCO Model显示文摘	Chris Knight Paul Howard Christine L. Baker Jeno P. Marton	2010	Value in Health2010，，：	2
2	Costs and Effects of Various Analgesic Treatments for Patients with Rheumatoid Arthritis and Osteoarthritis in The Netherlands显示文摘	Maiwenn J. Al Nikos Maniadakis Els W.M. Grijseels Matthijs Janssen	2008	Value in Health2008，，4：	1
3	Understanding the costs of care for cystic fibrosis: an analysis by age and health state显示文摘	Kees van Gool Richard Norman Martin B. Delatycki Jane Hall John Massie	2012	Value in Health2012，，：	1
4	Issues in drug pricing, reim- bursement, and access in China with references to other A- sia-Pacific region 显示文摘	Chen Y Schweitzer S O	2008	Value in Health2008，2，1：	1
5	PCN6 economical evaluation of raltitrexed versus fluorouraeil plus leucovorin (5-fu + Iv) for treatment of ad- vanced colorectal cancer显示文摘	Vorobyov P Sura M Avxentieva M	2002	Value in Health2002，5，6：	1
6	Analyses of Cost Data in Economic Evaluations Conducted Alongside Randomized Controlled Trials显示文摘	Jalpa A. Doshi Henry A. Glick Daniel Polsky	2006	Value in Health2006，，5：	1
7	Cost-effectiveness of nucleoside analog therapy for hepatitis B in China: a Markov analysis 显示文摘	Wu B Li T Chen H	2010	Value in Health2010，13，5：	1
8	Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations 显示文摘	Dyfrig Hughes	2007	Value in Health2007，10，6：	1
9	Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR RCT-CEA Task Force Report显示文摘	Scott Ramsey Richard Willke Andrew Briggs Ruth Brown Martin Buxton Anita Chawla John Cook Henry Glick Bengt Liljas Diana Petitti Shelby Reed	2005	Value in Health2005，，5：	1
10	Incorporating the patient's perspective into drug development and communication: An ad hoc task force report of the patient reported outcomes (PRO) harmonization group meeting at the food and drug administration显示文摘	Acquardo C Berzon R Dubois D	2001	Value in Health2001，6，5：	1
11	Evidence- based decision-making in Asia-Pacific with rapidly chan- ging health-care systems: Thailand, South Korea, and Tai- wan显示文摘	Jirawattanapisal T Kingkaew P Lee T J	2009	Value in Health2009，12，3：	1
12	Evidence- based decision on medical technologies in Asia Pacific: ex- periences from India, Malaysia, Philippines, and Pakistan 显示文摘	Thatte U Hussain S de Rosas-Valera M	2009	Value in Health2009，12，3：	1
13	Optimal cost-effec tiveness decisions: the role of the cost effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfect informa tion(EVPI) 显示文摘	Barton GR Briggs AH Fenwiek EAL	2008	Value in Health2008，11，5：	1
14	Evaluation of GLP- 1 product attributes in treating people with type-2 diabetes in US : Comparing time-tradeoff and willingness-to-pay methodologies 显示文摘	Zanutto E Conner C Polster M	2009	Value in Health2009，12，：	1
15	Cost-effectiveness of infliximab for the treatment of active and progressive psoriatic arthritis显示文摘	Ewen C Christian A Yogesh SP	2011	Value in Health2011，14，1：	1
16	Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluations Publication Guidelines Good Reporting Practices Task Force显示文摘	Don Husereau Michael Drummond Stavros Petrou Chris Carswell David Moher Dan Greenberg Federico Augustovski Andrew H. Briggs Josephine Mauskopf Elizabeth Loder	2013	Value in Health2013，，：	1
17	Cost-effectiveness analysis of bevacizumab in combination with PC regimen versus PC regimen in non-small cell lung cancer treatment 显示文摘	Nguyen TTT Tran TYH	2014	Value in Health2014，17，3：	1
18	Cost-of-Illness Studies in the United States: A Systematic Review of Methodologies Used for Direct Cost显示文摘	Gerd Clabaugh Marcia M	2008	Value in Health2008，1，11：	1
19	Impact of the pan Canadian pricing alliance on time to listing in Canada显示文摘	Robertson C Zhang Y Bosnic N	2014	Value in Health2014，17，3：	1
20	Evidence-based pre- diction of statin use with lipid-panel data from the National Health and Nutrition Examination Survey 显示文摘	Gorevski E Bian B Kelton CM	2012	Value in Health2012，15，1：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示